GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
PROM1 | 9454 | LTM | Glioblastoma | NA | U-373 | NA | SFA and IF staining followed by qRT-PCR and FACs | NA | 0.56 | 0.7582 | 26030909
|
HIF1A | 4910 | LTM | Glioblastoma | NA | U-373MG | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0106 | 29115404
|
MAPK3 | 6877 | LTM | Glioblastoma | NA | U-373MG | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0032 | 29115404
|
MET | 7029 | LTM | Glioblastoma | NA | U-373MG | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0191 | 29115404
|
NANOG | 20857 | LTM | Glioblastoma | NA | U-373MG | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5461 | 29115404
|
PROM1 | 9454 | LTM | Glioblastoma | NA | U-373MG | NA | SFA followed by Western Blotting | NA | 0.28 | 0.7582 | 29115404
|
PROM1 | 9454 | LTM | Glioblastoma | NA | U-373MG | NA | SFA followed by Western Blotting | NA | 0.28 | 0.7582 | 29115404
|
SOX2 | 11195 | LTM | Glioblastoma | NA | U-373MG | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5695 | 29115404
|
STAT3 | 11364 | LTM | Glioblastoma | NA | U-373MG | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0223 | 29115404
|
VEGF | 12680 | LTM | Glioblastoma | NA | U-373MG | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0042 | 29115404
|